Pharmacogenetic-Supported Prescribing in Kids (PGx-SParK)
Summary
Many children and teens with mental health conditions like depression, anxiety, or OCD are given medications, either on their own or along with therapy. But up to half of these young people do not get better from the medication or may have unwanted side effects. Today, treatment for children often works through trial and error, which can be stressful for both youth and their families. Pharmacogenetic (PGx) testing could help avoid this. PGx testing is a type of genetic test that looks at a person’s genes to see how quickly their body breaks down certain medications. This information can help doctors choose medication and dosage for each child.
Our goal is to create and test a strategy for adding PGx testing into youth mental health care in Alberta.
Eligibility
Eligible ages: 6 to 24
Inclusion criteria:
1. Aged 6 – 24 years
2. Has an Alberta Health Number
3. Testing requested by the treating physician licensed in Alberta
4. Will be starting or changing a psychiatric medication(s) that has a pharmacogenetic (PGx) recommendation to report.
Exclusion criteria:
1. Unwillingness to provide saliva sample for genetic analysis
2. History of liver or bone marrow (hematopoietic cell) transplant
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
By physician referral only - specific information required.
Principal investigator:
Chad Bousman
Clinical trial:
No
REB-ID:
REB25-1367